All posts by imreal

Industry: Healthcare

VirTrial Awarded FDA-Approved Decentralized Clinical Trial with Hope Biosciences

Leave a comment


News Image

Together, we are able to safely deliver and monitor our therapies for patients in the comfort of their homes. What this means for the world of cell therapy is nothing short of groundbreaking!


SCOTTSDALE, Ariz. (PRWEB)

VirTrial has been awarded an FDA-approved hybrid decentralized clinical trial (DCT) with Hope Biosciences. The study provides Hope Biosciences’ autologous, adipose-derived culture-expanded mesenchymal stem cells (HB-adMSC’s) for the treatment of spinal cord injury/disorder (SCI/D). Study protocol incorporates remote visits via VirTrial’s telehealth platform.

“After reviewing countless vendors, we found that VirTrial met our needs as a sponsor and most importantly, patient needs. VirTrial’s partnership in our trial has opened doors for patients who would otherwise be unable to participate due to health and lack of mobility,” stated Donna Chang, President and CEO of Hope Biosciences. “Together, we are able to safely deliver and monitor our therapies for patients in the comfort of their homes. What this means for the world of cell therapy is nothing short of groundbreaking!”

A hybrid decentralized clinical trial eliminates barriers to participation for SCI/D patients who have limited access to travel or suffer from the physical toll travel takes on them. Remote visits limit the demand for all visits to be done in-person. At each remote visit, a registered nurse visits the patient in their home and in conjunction with the physician, who is connected via the telehealth platform, conducts a physical exam. Once the physician gives the approval, the RN can administer the stem cell infusion to the patient in their home.

Mark Hanley, CEO of VirTrial, stated, “VirTrial’s telehealth platform reduces the burden associated with patient participation and makes it possible to recruit patients from a larger geographic area. I applaud progressive sponsors like Hope Biosciences who are embracing virtual trial technology to better serve the patient population and advance the clinical trials industry as a whole.”

Sherry Diers, RN, Clinical Affairs Specialist, Hope Biosciences commented, “The logistics and the physical toll for patients can be substantial. Using the VirTrial platform makes it possible for Hope to reach across hundreds of miles and deliver treatment.”

For more information on VirTrial’s offerings for pharmaceutical sponsors, go to https://virtrial.com/pharmaceuticals

About VirTrial

VirTrial is a technology company using a stable, long-standing telehealth platform to transform the clinical trials industry. The platform offers a Virtual Care Management (VCM) program that combines video, text, and email allowing pharmaceutical companies and CROs to create patient centric trials by replacing some study visits with virtual visits. The vision is for 25-50% of the visits to be conducted virtually creating a hybrid model. This model is ideally suited for Phase III/Phase IV trials where patient compliance can be assessed from any location. Our Virtual Care Management (VCM) program allows sites to review and assess patient compliance. The VirTrial app is supported on any device (Apple, Android, tablet and/or computer) and can be used by any site. It is hosted in a secure, cloud-based, environment and is HIPAA compliant.

VirTrial enables greater accessibility to trials for patients, higher performance by clinical trial sites, and improved outcomes for pharmaceutical companies. Working together we can bring better medications to market more quickly. To learn more about VirTrial, visit https://www.virtrial.com

About Hope Biosciences

Hope Biosciences is a clinical stage biotechnology company focused on developing novel cell-based therapeutics for acute and chronic injury and disease. Hope Bio’s core technology lies in stem cell culture and banking. Mesenchymal stem cells are isolated from approximately one tablespoon of a patient’s own fat tissue, purified, and cultured with Hope Bio’s proprietary culture media, HB-101. HB-adMSCs are expanded to multiple passages and released at Passage 4 for therapeutic use. Samples of each passage are banked in order to create a master cell bank for each patient, which will be used to make additional therapies in the future. HB-adMSCs have already been used as a safe and effective treatment in a Phase I/IIa clinical trial for Rheumatoid Arthritis and Individual Expanded Access IND for Parkinson’s disease, Cerebral Palsy, Spinal Cord Injury and Thrombotic Thrombocytopenic Purpura. To learn more about HOPE Biosciences, visit https://www.hope.bio

Share article on social media or email:

Business: Executives

Damon Griggs to Lead Dovel Technologies as CEO

Leave a comment



MCLEAN, Va. (PRWEB)

Dovel Technologies, a leading expert to federal agencies that blends deep domain expertise and advanced technologies in the health IT, life sciences, and grants management markets, today announced that President and Chief Operating Officer Damon Griggs will become Chief Executive Officer of the company effective November 1, 2019. As part of this long-planned succession, current CEO, Paul Leslie, will transition to Executive Chairman of the Board.

Dovel helps advance federal agency missions to bring meaningful change to improve, protect, and save lives. The company has a long, proven history of integrating emerging technologies with domain expertise, mission requirements, and customer needs to produce lasting and highly innovative solutions.

Griggs joined the company in 2016 in the role of COO and assumed the responsibilities of President in 2018. Since Griggs’ arrival, Dovel has more than doubled in size and has built out its infrastructure in preparation for the next phase of growth, including the recent acquisition of Ace Info Solutions. He has been instrumental in the development of Dovel’s corporate strategy, focusing on expanding capabilities, enhancing relationships with current and prospective customers, and providing opportunities for employee growth.

“The Dovel team takes enormous pride in the design, development, and delivery of innovative solutions that fundamentally enable our customers to meet their mission. I am dedicated to continuing to foster a culture of innovation, remaining committed in our customer centricity, while elevating our position as an employer of choice,” said Griggs. “With our ongoing development and expansion of competencies and capabilities, as well as access to a wide-range of contract vehicles, Dovel will continue to provide cutting-edge solutions and expand our reach to broaden our impact across the federal government.”

Leslie joined Dovel as CEO in 2011. In that time, he led the growth of the company from a small business with less than 50 employees into a significant player in the federal government space with over 2,200 personnel today. With Leslie’s vision and leadership, Dovel focused on the health IT, life sciences, and grants management markets, building a unique team by combining subject matter experts to support the technologists, creating solutions for clients working in these complex and data-rich environments.

“I am so grateful to Damon for the outstanding support and exceptional leadership he has provided me and the Dovel team. Succession planning has been a critical component of our strategy as we looked to the future, including the timing of this transition,” commented Leslie. “I have tremendous confidence in Damon and the executive team and look forward to this next chapter in Dovel’s evolution as we continue to expand our capabilities to help our customers create the government of the future.”

About Dovel Technologies

Dovel Technologies blends deep domain expertise with advanced technologies to accelerate solutions that best fit the needs of our customers. We apply deep subject matter experience in health IT, life sciences, and grants management to drive innovation and expand customer capabilities. We harness the power of emerging technologies to integrate complex systems and manage information, allowing for rapid decision-making in data-rich environments. In May 2019,    Dovel received a significant capital investment from Macquarie Capital, the corporate advisory, capital markets, and principal investment arm of Macquarie Group. For more information visit http://www.doveltech.com

Contact:

Piper Conrad

piper.conrad@doveltech.com

571-499-3718

Share article on social media or email:

Health

Prominent Cardiologist Dr. Apurva Shah Receives Castle Connolly’s 2019 Top Doctor® Award for the Seventh Consecutive Year

Leave a comment


News Image

It is always an honor to be recognized by my peers. Being included on a list with so many talented physicians as a 2019 Castle Connolly Top Doctor, is quite the compliment. I will continue my commitment to improving the health and well-being of my patients, says Dr. Apurva Shah


ATLANTA (PRWEB)

Dr. Apurva Shah has once again been recognized as a 2019 Castle Connolly Top Doctor. Recipients of this award were nominated by their fellow doctors, and it is a highly selective list. Those who are among the very best in their specialties are chosen for inclusion. Dr. Shah is board-certified in cardiology. Currently, he is a physician at Northside Heart, which is one of North Atlanta’s largest groups providing cardiology services, with multiple locations throughout the area. Practicing primarily out of the Woodstock office, Dr. Shah specializes in cardiovascular diseases and in non-invasive cardiology. He has a particular interest in cardiovascular imaging, including cardiac perfusion studies, echocardiography and cardiac CT. Dr. Apurva Shah is a trusted physician who is dedicated to providing his patients with top-quality medical care. Many of Dr. Shah’s highly-satisfied patients have shared that he is an excellent communicator, attentive and exceptionally knowledgeable in his field.

“It is always an honor to be recognized by my peers. Being included on a list with so many talented physicians as a 2019 Castle Connolly Top Doctor, is quite the compliment. I will continue my commitment to improving the health and well-being of my patients,” says Dr. Apurva Shah

About Castle Connolly and America’s Top Doctors ®

The mission of Castle Connolly Medical Ltd. is to help consumers find the best healthcare. The top doctors who are listed on their books and website directory were nominated by peers in an extensive survey process of thousands of American doctors each year. These Top Doctors’ medical educations, training, hospital appointments and disciplinary histories are rigorously screened by the Castle Connolly physician-led research team. Doctors do not and cannot pay to be included in any Castle Connolly Guide or online directory.

More about Dr. Apurva Shah

Dr. Shah has been practicing medicine for the past twenty years. He completed his medical school training at the Chicago Medical School and his internal medicine residency at Thomas Jefferson University Hospital in Philadelphia, PA. His cardiology fellowship was performed at the University of Medicine and Dentistry/Robert Wood Johnson Medical School of New Jersey. During that training, he also spent time at the Deborah Heart and Lung Transplant Center. He has been practicing medicine in the Atlanta, Georgia area since 2005.

To schedule an appointment or learn more about Dr. Apurva Shah and Northside Heart please call 770-924-5095 or visit http://www.northsideheart.com/physician/apurva-shah. His Top Doctor profile may also be reviewed on http://www.castleconnolly.com.

Share article on social media or email:

Industry: Healthcare

RealTime Software Solutions Announces They Have Joined SCRS Global Impact Partner Program

Leave a comment


The GIP program gives us the opportunity to listen and contribute on a whole new level


SAN ANTONIO (PRWEB)

As a dedicated leader in the clinical trial industry, RealTime Software Solutions is pleased to announce that they have joined the Society for Clinical Research Sites Global Impact Partner (GIP) Program.

RealTime CEO Rick Greenfield, a long-time member of SCRS, says the partnership is just another way for the company to come together with industry leaders to help streamline the way research is done.

“As a long-time attendee of the Site Solutions Summit and proud member of SCRS, I have seen first-hand the difference that SCRS has made for clinical research sites and the research industry as a whole,” says Greenfield. “I could not be prouder to bring RealTime into the GIP family at SCRS and to join the cause for better processes, systems and best practices that will improve the clinical research landscape for Sites, CROs and Sponsors alike. At RealTime, we prioritize the needs of the industry so we can offer solutions that truly make a difference. The GIP program gives us the opportunity to listen and contribute on a whole new level.”

As a member of GIP, RealTime will have the opportunity to work directly with major players in all facets of the clinical research industry to include large-scale CROs, data vendors, service providers, sites and site networks that all have a hand in shaping clinical research.

Members also benefit by having a seat on the GIP board which interfaces with SCRS leadership to set strategic initiatives for the Society. SCRS GIP members may also elect to engage the SCRS community for individual corporate objectives using SCRS program options that include focus groups, surveys, research, content development, and geographic or regional site support.

To learn more about RealTime Software Solutions, visit RealTime-CTMS.com.

About RealTime Software Solutions

Founded in February of 2013, RealTime Software Solutions, LLC strives to bring innovative Clinical Trial Management Systems (CTMS) to sites, CROs and sponsors of all shapes and sizes. The core values of RealTime include, “Innovation Now”, “Think Like Customers” and “Integrity Always”. These values have helped RealTime grow into a leading CTMS provider for systems like SitePAY, GlobalPAY, eDOCS and eSOURCE for thousands of customers around the world. RealTime will continue the pursuit of advanced systems and processes that enhance the workflow and efficiency of all stakeholders within the clinical research execution process. Visit RealTime-CTMS.com to learn more.

Share article on social media or email:

Business: Executives

LeaseAccelerator’s Michael Keeler Named to the 2019 Washingtonian Magazine Tech Titans List

Leave a comment


“I am honored to be named to the 2019 Washingtonian Magazine Tech Titan List and join a peer group that consists of many of the Washington DC area’s most successful, high-growth companies,” said Michael Keeler, CEO of LeaseAccelerator.


RESTON, Va. (PRWEB)

Michael Keeler, the CEO and Founder of LeaseAccelerator and pioneer in the Enterprise Lease Accounting software market, has been named to the Washingtonian Magazine Tech Titans 2019 List as an Entrepreneur Honoree. The annual list published by Washingtonian Magazine identifies the most important and innovative people in Washington’s digital economy. The award ceremony is scheduled to take place on Tuesday, October 29th, 2019 from 6 p.m. to 9 p.m at the 12 Stories lounge in Washington D.C.

Michael Keeler founded LeaseAccelerator in 2003 as the first enterprise application software company focused on automating the business processes for managing global corporate leasing processes. Over the past few years, Keeler has led LeaseAccelerator through a period of explosive growth which included a $30M growth equity funding from Insight Partners, which fueled LeaseAccelerator’s recent expansion in Europe and Asia Pacific.

With over $3 trillion in spend worldwide, leasing is one of the last major business processes yet to be significantly disrupted by technology. Since its inception LeaseAccelerator’s mission has been to help businesses of all sizes automate the sourcing, management, and accounting of their real estate and equipment lease portfolios. New accounting standards introduced in 2016 have significantly compounded the challenges as businesses must now track the rent and contract terms of each and every leased asset to provide accurate reporting to their shareholders. Even small companies are struggling as they find that spreadsheets and low-budget leasing applications are not adequate to comply with these new rules.

“I am honored to be named to the 2019 Washingtonian Magazine Tech Titan List and join a peer group that consists of many of the Washington DC area’s most successful, high-growth companies,” said Michael Keeler, CEO of LeaseAccelerator. “The entire LeaseAccelerator team should be recognized for our achievements in developing this new category of Enterprise Lease Accounting software. It took hundreds of incremental innovations by the many wonderful entrepreneurs in our company to take such a complex business process as lease accounting and make it so simple and fast for our customers,” noted Keeler.

To read the full profile of Michael Keeler visit the Washingtonian Magazine website at: https://www.washingtonian.com/2019/10/03/tech-titans-2019-washingtons-top-tech-leaders/#The-Entrepreneurs

About LeaseAccelerator:

LeaseAccelerator offers the market-leading SaaS solution for Enterprise Lease Accounting, enabling compliance with the new ASC 842, IFRS 16 and GASB 87 standards. Using LeaseAccelerator’s proprietary Global Lease Accounting Engine, customers can apply the new standards to all categories of leases including real estate, fleet, IT and other equipment at an asset-level. LeaseAccelerator’s Real Estate, Lease Sourcing, and Lease Management applications generate considerable savings through smarter procurement and easier management. Learn more at: http://www.leaseaccelerator.com/.

Share article on social media or email:

Health

ImPACT Applications Successfully Meets Standards of the Medical Device Single Audit Program (MDSAP)

Leave a comment


“Passing the MDSAP is a major accomplishment and yet another example of ImPACT Applications, Inc.’s commitment to quality and compliance.”


SAN DIEGO (PRWEB)

ImPACT Applications successfully passes the intensive Medical Device Single Audit Program (MDSAP) and obtains ISO 13485 re-certification. The audit requires full transparency with the quality management system structure, corrective action and preventive action, software development lifecycle, and IT infrastructure to ensure the public’s security and privacy.

“Choosing to participate in the MDSAP wasn’t a question for us,” said Michael Zagorski, ImPACT Applications’ Director of Regulatory Affairs and Privacy Officer. “Everything from our company procedures to staff training and privacy practices is geared towards making products people can trust.”

MDSAP was created with the goal to unify medical device audit standards to improve their safety and oversight on a global scale. As a worldwide leader in concussion management software, ImPACT Applications is well-equipped to address evolving regulatory agencies’ standards.

Along with being regulatory compliant, ImPACT Applications’ products have over 500 plus research articles (https://concussionresearch.com/) containing independent and peer-reviewed studies that help healthcare providers validate the use of their concussion assessment tools.

“Passing the MDSAP is a major accomplishment and yet another example of ImPACT Applications, Inc.’s commitment to quality and compliance,” said Michael Wahlster, ImPACT Applications’ Chief Executive Officer. “This multi-country audit is necessary for an industry that sees rapid innovation and will help ensure medical device companies prioritize public safety.”

About ImPACT Applications:

ImPACT Applications, Inc. is the maker of ImPACT®, ImPACT Pediatric®, and ImPACT Quick Test®, all FDA cleared Class I & II medical devices that assist in the assessment and management of concussion. ImPACT Applications also offers the FDA cleared ImPACT Baseline Test to home-based users worldwide.

ImPACT Applications products are used by most major medical centers, professional sports leagues and teams, colleges, high schools, and select military units. Since 2002, ImPACT Applications has administered more than 18 million tests to over 11 million users. For more information, visit https://impacttest.com/.

Share article on social media or email:

Technology: Electronics

LaserTech Helps Police Departments See Clearly with Technology of the Future.

Leave a comment


If you’ve been thinking about upgrading or equipping each of your officers with their own LIDAR traffic enforcement devices, now is the time!


CENTENNIAL, Colo. (PRWEB)

Laser Technology, Inc. (LTI) is starting a countdown to their most commemorative year yet. 29 years ago, LTI aptly named its first speed enforcement device the LTI 20/20. Drawn from the idea that 20/20 describes perfect visual acuity, this brand name established immense distinction from radar equipment of the day and the pinpoint accuracy of LTI lidar devices.

Lidar is a great tool for highly trafficked areas and providing indisputable documentation. With 2020 being a monumental year for the company, LTI is starting their 20/20 trademark festivities early with an impressive promotion for your department.

If you’ve been thinking about upgrading or equipping each of your officers with their own lidar traffic enforcement devices, now is the time! Starting October 1, 2019 and running through December 31, 2019, LTI’s 20/20 TruSpeed® S and TruVISION™ price will be reduced.

The TruSpeed® S, LTI’s lightweight and compact device sits perfectly in a vest pocket or holster for your officers who spend their time enforcing on a motor, or who prefer resilient and tough devices that weigh-in at under 1 pound. The TruSpeed S’s compact size does not minimize how powerful this handheld tool is. With a range of 2000 ft, spread of 2.5 ft at 1000ft, with 7X magnification, the pinpoint accuracy of this device will make an impactful addition to your speed enforcement tool box. This unit has an original MSRP value of $1,495, however, during this special pricing period, you can receive this incredible unit for only $995.

If you are looking for the most advanced handheld all-in-one lidar device, the TruVISION device is the go-to, all-in-one device that yields a chain of evidence with photo and video documentation for most traffic violations: following too close, speed, unrestrained occupants, misuse of HOV lanes, distracted driving, and more. Originally priced at $6,995 MSRP, the TruVISION will be reduced to the price of $4,995. The TruVISION’s rear plate mode and easy integration to your back-office ticketing system makes this more than a speed enforcement device but, rather, a complete solution.

For more information, please reach out to Laser Technology at 303.649.1000 or 877.696.2584

About Laser Technology, Inc.

Laser Technology, Inc. is a Colorado-based manufacturer devoted to the design and manufacture of innovative laser-based speed and distance measurement instruments to address real-world needs and applications, including speed enforcement, incident investigation, forestry, mining, utilities, surveying, and industrial process control. Visit lasertech.com for additional information.

Share article on social media or email:

Industry: Healthcare

The first International Sigma Anti-Bonding Calcium Symposium (ISACS 2019) by CBHI

Leave a comment


https://www.prweb.com/

ISACS 2019

I hope more people be aware of the importance of bone health and the available solutions for their bodies.


VANCOUVER, British Columbia (PRWEB)

Calcium & Bone Health Institute (CBHI) held International Sigma Anti-Bonding Calcium Symposium (ISACS) 2019 at Executive Plaza Hotel in Vancouver, Canada on September 23-24 for two days. The purpose of symposium was to discuss and share the knowledge of the various measures to develop healthy bone and to prevent calcium-related diseases. The theme of this year was “The Secret of Reversible Bone Health”.

“While serving as the president of CBHI which conducts intensive research about the significance of calcium for the human body, I thought of a place where researchers and professors come together to share their knowledge and create synergy effect in their research field,” said Dr. Paul Lee, the ISACS Chair. “I am very grateful that we could start the first Symposium in Vancouver, Canada. I hope more people be aware of the importance of bone health and the available solutions for their bodies.”

The speakers included researchers, professors, dentists, pharmacists, businessmen and patients. People from U.S.A., Canada, Korea, China, Indonesia, and Japan attended in the event. The topics by speakers ranged from cancer, bone, dental treatment, and arrhythmias, to diabetes. Testimonials by patients with SAC treatment were also presented.

SAC (Sigma Anti-Bonding Calcium) calcium was invented by Dr. Paul Lee in 2009. The atomic orbitals of SAC calcium molecule have sigma anti-bonding and therefore, easily separated into atoms in the water, absorbed in the body in the ionic form, Ca++. It is 200 times more soluble in water and has shown up to 80% bone mineral density increase in thousands of people. SAC calcium awakens body’s dormant response and the process is fully natural without side effect.

As the first ISACS 2019 was successfully held, CBHI plans to hold the event internationally following years.

About CBHI

Calcium and Bone Health Institute (CBHI) is Canada based research organization that has invented Sigma Anti-bonding Calcium (SAC). It has partnership with many universities and research organizations. Its invented SAC calcium was tried by thousands of people with great responses from their bodies. It continues to research on many challenging diseases such as osteoporosis, cancer, stem cell, diabetes, Alzheimer’s disease and more.

Share article on social media or email:

Health: Psychology

Unique take on depression has people feeling good—about feeling bad

Leave a comment


https://www.prweb.com/

Book cover for THE INVENTION OF EVERYTHING: Insights on Life, Food, and one good Thermos.

“Being a part of those around us is the agreement you sign when you join the human race.”


DOVER, Del. (PRWEB)

“It was very unexpected,” says author Everett De Morier. “This article took on a life of its own.”

Everett De Morier is a humorist and award-winning author who, for the past three years, has been editor-in-chief of 543 Magazine. And this week, De Morier posted an article about depression in middle-aged people.

“I mean, the piece was a lot more personal than I like to get,” said De Morier. “I had to admit some things that I was struggling with, but overall I expected it to be read by the same amount of readers as all the other articles.”

543 Magazine has a solid number of loyal readers and even had its best-of articles turned into a book called The Invention of Everything: Insights on Life, Food, and One Good Thermos, published in 2018 by Blydyn Square Books. 543 Magazine also produced the 2018 documentary Binghamton: Valley of Creativity.

But the reaction to the article entitled “The Depression Agreement” was completely unexpected.

De Morier said, “The website had a small number of direct comments to the articles. People don’t usually comment on the site; they share on social media. But shortly after the article went live, my email exploded.”

In two days, “The Depression Agreement” received five times as many comments as the entire website had garnered in over three years. All of them were extremely positive.

“I guess it shows how important a topic depression is, but more importantly I think people responded to the fact that depression is a kind of a selfish act and we need to change that. And we do that be staying involved with those around us which leads to us actually feeling sort of good about feeling bad.”

“The Depression Agreement” article can be found at https://543magazine.com/the-depression-agreement/#disqus_thread

Share article on social media or email:

Business: Executives

Construction Audit & Cost Control Institute Announces NEW Workshop, “Best Practices for Using CMAR and Design Build Construction Contracts in Texas,” Nov. 14-15 in Austin

Leave a comment


https://www.prweb.com/

Hilton-Austin: views of the Capitol of Texas, spa, VIP perks and a quick walk to amazing restaurants, exclusive shopping and live music venues.

You seem to always have speakers with the current pulse of the industry.


AUSTIN, Texas (PRWEB)

The Construction Audit & Cost Control Institute is offering a new workshop, “Best Practices for Using CMAR and Design Build Contracts in Texas” November 14-15, 2019 in Austin, Texas. This training event was designed for public school systems, community college systems, state and local governments, airports, etc.

Included are several networking opportunities: an evening reception, breakfast, refreshment breaks and lunch will be provided by Hilton both days.

Course Level: Intermediate

CPE Hours: 12

Space is limited. Reserve your seat now (option to pay later).

LEARN MORE: Speaker’s Biographies, Complete Learning Objectives, CPE, Venue, etc.

Who Will Benefit from this Program:


  • Architects

  • Attorneys

  • CFO’s and Controllers

  • Construction Audit Consultants

  • Construction and Engineering Department Representatives

  • Contract Administrators

  • Cost Engineers

  • Facilities Management Department Representatives

  • Internal Audit Professionals

  • Procurement Department Representatives

  • Program Managers

Reviews from Previous Training Participants:

“Liked the interactive discussions about current trends.”

“I enjoyed the presentations immensely. Each presenter added value and a different point of view. I felt that I picked up many issues to look for.”

“Opened my mind to new thoughts in construction auditing.”

“This course was one of the best audit classes taken in a long time. Valuable and relevant.”

“Very relevant – making me think about how to change my audit approach to be more effective.”

“Overall the information was on target. Very beneficial.”

Sample Learning Objectives:

  •     Learn the latest best practices in use for construction cost control:


         – Creating CM contracts to close loopholes that can increase construction costs significantly

         – Reviewing and approving GMP submittals by CM’s

         – Reviewing, approving and tracking GMP subcontract buy-out gains or losses

         – Requiring supporting documentation for payment applications and reconciling CM cost records and related documentation to their final cost accounting

         – Analysis, approval and audit of change orders proposals submitted by CM and subcontractors

  •     Learn the pros and cons of reimbursables including labor and labor burden, performance and payment bonds, Subcontractor default insurance, Contractor Controlled Insurance and more

  •     Obtain an update on the trends in tools and techniques used for construction audit and cost control

  •     Explore specific case example results of current best practice contracts

  •     Have your questions answered during our Q&A sessions at the conclusion of each presentation

We are inviting each presenter to make a 50-minute presentation (with 15 minutes for Q&A) on the following:

  •     The top 3 keys to success in contracting for and managing Cost plus Fee with GMP CMAR and/or Design Build contracts in Texas.

  •     The 3 top mistakes to avoid when contracting for and managing Cost plus Fee CMAR and/or Design Build contracts in Texas.

  •     Project experiences (including what went well and what could have gone better)

  •     Recommendations for best practices when using these types of reimbursable costs with GMP contracts.

Presenters:

1.    Stephen Harris – Asst. Vice Chancellor for Capital Projects – University of Texas System Administration

2.    Dick McNary – President & Chief Operating Officer – Project Control

3.    Charles D. Smith – Associate Vice Chancellor, Fiscal Initiatives & Construction – San Jacinto College District

4.    Angela Tekell – Partner – Tekell & Tekell, LLP

5.    Debbie Townsend – President – R. L. Townsend & Associates, LLC

6.    Rich Townsend – President – Construction Audit & Cost Control Institute, Inc.

7.    Russ Wallace – Executive Director, Office of Facilities Planning & Construction – The Texas A&M University System

8.    Vince Yauger – Senior Project Manager – Broaddus & Associates

Venue: Hilton-Austin

Hilton Austin is situated adjacent to the Convention Center in downtown Austin, TX. A quick walk from exclusive shopping, amazing restaurants and fun live music venues on 6th Street and the surrounding area. Guests of the renovated hotel also enjoy fantastic views of the Capitol of Texas and Lady Bird Lake from 31 stories up. Hotel dining, a full-service spa and VIP perks.

Course Level: Intermediate

CPE Hours: 12

Space is limited. Reserve your seat now (option to pay later).

LEARN MORE: Speaker’s BIographies, Learning Objectives, CPE, Venue, etc.

Sponsor:

The Construction Audit & Cost Control Institute was established in 2008 to provide specific professional development training seminars to professionals interested in this specialized subject matter. Rich Townsend has provided development seminars related to construction audit and construction cost control seminars since 1985. For more information on our construction audit and fraud seminars, go to http://www.caacci.org

Share article on social media or email: